CCNG2 and gestational diabetes: Cell cycle inhibitor CCNG2 showed significantly increased expression in placentas obtained from pregnancies complicated by maternal PE (t-test P = 4.3×10−4; FDR P<0.05; fc = 1.49) or GDM (P = 5.7×10−4; FDR P<0.05; fc = 1.46), and also from deliveries resulted in the birth of LGA babies (P = 0.027, fc = 1.23).